Diagnostic Accuracy of the Abbott BinaxNOW COVID-19 Antigen Card Test, Puerto Rico.
Zachary J MadewellChelsea G MajorNathan GraffCameron AdamsDania M RodriguezTatiana MoralesNicole A Medina LopesRafael TosadoLiliana Sánchez-GonzálezJanice Perez-PadillaHannah R VolkmanJorge Bertrán-PasarellDiego Sainz de la PeñaJorge Munoz-JordanGilberto A SantiagoOlga LorenziVanessa Rivera-AmillMelissa A R RolfesGabriela Paz-BaileyLaura E AdamsJoshua M WongPublished in: Influenza and other respiratory viruses (2024)
BinaxNOW demonstrated high sensitivity and specificity, particularly in early-stage infections and symptomatic participants. In situations where test sensitivity is crucial for clinical decision-making, nucleic acid amplification tests are preferred. These findings highlight the importance of considering clinical and epidemiological context when interpreting test results and emphasize the need for ongoing research to adapt testing strategies to emerging SARS-CoV-2 variants.